A Well-Defined Magnesium Complex of C .

Controlling and understanding charge state and metal coordination in carbon nanomaterials is crucial to harnessing their unique properties. Here we describe the synthesis of the well-defined fulleride complex [{(nacnac)Mg}C], 2, (nacnac)=HC(MeCNMes), Mes=2,4,6-MeCH, from the reaction of the β-diketiminate magnesium(I) complex [{(nacnac)Mg}] with C in aromatic solvents. The molecular structure of complex 2 was determined, providing the first high-quality structural study of a complex with the C ion.

A Convenient One-Pot Synthesis of a Sterically Demanding Aniline from Aryllithium Using Trimethylsilyl Azide, Conversion to -Diketimines and Synthesis of a -Diketiminate Magnesium Hydride Complex.

This work reports the one-pot synthesis of sterically demanding aniline derivatives from aryllithium species utilising trimethylsilyl azide to introduce amine functionalities and conversions to new examples of a common '-chelating ligand system. The reaction of TripLi (Trip = 2,4,6-Pr-CH) with trimethylsilyl azide afforded the silyltriazene TripNN(SiMe) in situ, which readily reacts with methanol under dinitrogen elimination to the aniline TripNH in good yield. The reaction pathways and by-products of the system have been studied.

Diabetes mellitus type 1 in children and adolescents in Moscow. Data from the Moscow Segment of the Federal Register of Diabetic Patients 2015-2020.

Background: Therapy for type 1 diabetes mellitus (T1DM) is still largely an unsolved clinical problem. Despite the introduction into clinical practice of modern insulin preparations, devices for its administration, as well as continuous monitoring of glucose levels, the goals of therapy are often not achieved. At the same time, the International Diabetes Federation (IDF) notes an increase in the prevalence and incidence of T1DM in children and adolescents in the world.

[Resolution on the results of the first working meeting of the Scientific Advisory Board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»].

June 19, 2018 the meeting of the Scientific Advisory Board took place in Moscow, chaired by Professor G.R. Galstyan, (co-chair - A.